Your browser doesn't support javascript.
loading
Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan and S-1 (OX-IRIS) as first-line treatment for metastatic or relapsed pancreatic cancer.
Nakano, Shintaro; Kawamoto, Yasuyuki; Yuki, Satoshi; Harada, Kazuaki; Miyagishima, Takuto; Sogabe, Susumu; Dazai, Masayoshi; Sato, Atsushi; Ishiguro, Atsushi; Nakamura, Michio; Kajiura, Shinya; Takahashi, Yasuo; Tateyama, Miki; Hatanaka, Kazuteru; Tsuji, Yasushi; Sasaki, Takahide; Shindo, Yoshiaki; Kobayashi, Tomoe; Yokota, Isao; Sakamoto, Naoya; Sakata, Yuh; Komatsu, Yoshito.
Afiliación
  • Nakano S; Division of Cancer Centre, Hokkaido University Hospital, Sapporo, Japan.
  • Kawamoto Y; Division of Cancer Centre, Hokkaido University Hospital, Sapporo, Japan.
  • Yuki S; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan.
  • Harada K; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan.
  • Miyagishima T; Department of Medical Oncology, Kushiro Rosai Hospital, Kushiro, Japan.
  • Sogabe S; Department of Medical Oncology, KKR Sapporo Medical Center, Sapporo, Japan.
  • Dazai M; Department of Gastroenterology, Sapporo Medical Center NTT EC, Sapporo, Japan.
  • Sato A; Department of Medical Oncology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Ishiguro A; Department of Medical Oncology, Teine Keijinkai Hospital, Sapporo, Japan.
  • Nakamura M; Department of Gastroenterology, Sapporo City General Hospital, Sapporo, Japan.
  • Kajiura S; Department of Gastroenterology and Hematology, Faculty of medicine, University of Toyama, Toyama, Japan.
  • Takahashi Y; Department of Gastroenterology, Hokkaido Cancer Centre, Sapporo, Japan.
  • Tateyama M; Division of Internal Medicine, Tomakomai Nisshou Hospital, Sapporo, Japan.
  • Hatanaka K; Department of Gastroenterology, Hakodate Municipal Hospital, Hakodate, Japan.
  • Tsuji Y; Department of Medical Oncology, Tonan Hospital, Sapporo, Japan.
  • Sasaki T; Department of Internal Medicine, Hokkaido Gastroenterology Hospital, Sapporo, Japan.
  • Shindo Y; Department of Gastroenterological Surgery, Nakadori General Hospital, Akita, Japan.
  • Kobayashi T; Department of Gastroenterology, Tomakomai City Hospital, Tomakomai, Japan.
  • Yokota I; Department of Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Sakamoto N; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan.
  • Sakata Y; CEO, Misawa City Hospital, Misawa, Japan.
  • Komatsu Y; Division of Cancer Centre, Hokkaido University Hospital, Sapporo, Japan ykomatsu@ac.cyberhome.ne.jp.
BMJ Open ; 12(5): e048833, 2022 05 09.
Article en En | MEDLINE | ID: mdl-35534074
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Guideline / Observational_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Guideline / Observational_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article País de afiliación: Japón